Status:
UNKNOWN
EMG-guided Botox Injection Versus Conventional Botox Injection in Gummy Smile Patients
Lead Sponsor:
Cairo University
Conditions:
Excessive Gingival Display
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to compare the effect of EMG-guided Botox injection with conventional Botox injection in Yonsei point, in patients with excessive gingival display. The main questio...
Eligibility Criteria
Inclusion
- Patients with excessive gingival display.
- Patients with esthetic concerns.
- Patients with mild to moderate VME (vertical maxillary excess).
- Normal clinical crown dimensions.
- Patients aged 18 to 50.
- Systemically healthy patients.
- Non-smokers.
Exclusion
- Patients with severe VME (vertical maxillary excess).
- Pregnant and breastfeeding women.
- Patients with gingival inflammation and/or enlargement.
- Inflammation or infection at the site of injection.
- Patients with known allergy to any of the components of Botox (i.e., saline, human albumin, lactose and sodium succinate).
- Patients using anticholinesterase or other agents affecting neuromuscular transmission.
- Psychologically unstable patients or those who have unrealistic expectations and questionable motives.
- Patients with neuromuscular disorders (e.g., myasthenia gravis, Eaton-Lambert syndrome).
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2024
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT06075134
Start Date
November 1 2023
End Date
August 1 2024
Last Update
October 10 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.